The DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
RNA Interference: From Basic Research to Therapeutic Applications
Open accessAbstract
An efficient mechanism for the sequence‐specific inhibition of gene expression is RNA interference. In this process, double‐stranded RNA molecules induce cleavage of a selected target RNA (see picture). This technique has in recent years developed into a standard method of molecular biology. Successful applications in animal models have already led to the initiation of RNAi‐based clinical trials as a new therapeutic option.magnified image Only ten years ago Andrew Fire and Craig Mello were able to show that double‐stranded RNA molecules could inhibit the expression of homologous genes in eukaryotes. This process, termed RNA interference, has developed into a standard method of molecular biology. This Review provides an overview of the molecular processes involved, with a particular focus on the posttranscriptional inhibition of gene expression in mammalian cells, the possible applications in research, and the results of the first clinical studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
Role for a bidentate ribonuclease in the initiation step of RNA interference
Bernstein, E., Caudy, A. A., Hammond, S. M., & Hannon, G. J. (2001) · Nature · doi:10.1038/35053110 · Cited by 4,892
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
RNA interference is mediated by 21- and 22-nucleotide RNAs
Elbashir, S. M., Lendeckel, W., & Tuschl, T. (2001) · Genes & Development · doi:10.1101/gad.862301 · Cited by 3,310
Asymmetry in the Assembly of the RNAi Enzyme Complex
Schwarz, D. S., Hutvágner, G., Du, T., Xu, Z., Aronin, N., & Zamore, P. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00759-1 · Cited by 2,922
Argonaute2 is the catalytic engine of mammalian RNAi
Liu, J., Carmell, M. A., Rivas, F. V., Marsden, C. G., Thomson, J. M., Song, J.-J., Hammond, S. M., Joshua-Tor, L., & Hannon, G. J. (2004) · Science · doi:10.1126/science.1102513 · Cited by 2,796
Bushati, N., & Cohen, S. M. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.23.090506.123406 · Cited by 2,750
Functional siRNAs and miRNAs exhibit strand bias
Khvorova, A., Reynolds, A., & Jayasena, S. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00801-8 · Cited by 2,645
Expression profiling reveals off-target gene regulation by RNAi
Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., & Linsley, P. S. (2003) · Nature Biotechnology · doi:10.1038/nbt831 · Cited by 2,370
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
Cavazzana-Calvo, M., Hacein-Bey, S., Basile, G. D. S., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.-L., et al. (2000) · Science · doi:10.1126/science.288.5466.669 · Cited by 2,167
Rational siRNA design for RNA interference
Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W. S., & Khvorova, A. (2004) · Nature Biotechnology · doi:10.1038/nbt936 · Cited by 2,094
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677
LNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589
Crystal Structure of Argonaute and Its Implications for RISC Slicer Activity
Song, J.-J., Smith, S. K., Hannon, G. J., & Joshua-Tor, L. (2004) · Science · doi:10.1126/science.1102514 · Cited by 1,470
Single-Stranded Antisense siRNAs Guide Target RNA Cleavage in RNAi
Martinez, J., Patkaniowska, A., Urlaub, H., Lührmann, R., & Tuschl, T. (2002) · Cell · doi:10.1016/s0092-8674(02)00908-x · Cited by 1,459
Identification of host proteins required for HIV infection through a functional genomic screen
Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J., & Elledge, S. J. (2008) · Science · doi:10.1126/science.1152725 · Cited by 1,449
Activation of the interferon system by short-interfering RNAs
Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H., & Williams, B. R. G. (2003) · Nature Cell Biology · doi:10.1038/ncb1038 · Cited by 1,400
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270
Doench, J. G., Petersen, C. P., & Sharp, P. A. (2003) · Genes & Development · doi:10.1101/gad.1064703 · Cited by 1,260
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250
Transvascular delivery of small interfering RNA to the central nervous system
Kumar, P., Wu, H., McBride, J. L., Jung, K.-E., Hee Kim, M., Davidson, B. L., Kyung Lee, S., Shankar, P., & Manjunath, N. (2007) · Nature · doi:10.1038/nature05901 · Cited by 1,246
Hornung, V., Guenthner-Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A., Manoharan, M., Akira, S., de Fougerolles, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1191 · Cited by 1,232
Passenger-Strand Cleavage Facilitates Assembly of siRNA into Ago2-Containing RNAi Enzyme Complexes
Matranga, C., Tomari, Y., Shin, C., Bartel, D. P., & Zamore, P. D. (2005) · Cell · doi:10.1016/j.cell.2005.08.044 · Cited by 1,211
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168
Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes
Watanabe, T., Totoki, Y., Toyoda, A., Kaneda, M., Kuramochi-Miyagawa, S., Obata, Y., Chiba, H., Kohara, Y., Kono, T., Nakano, T., et al. (2008) · Nature · doi:10.1038/nature06908 · Cited by 1,116
Napoli, C., Lemieux, C., & Jorgensen, R. (1990) · The Plant Cell · doi:10.2307/3869076 · Cited by 1,101
The Piwi-piRNA Pathway Provides an Adaptive Defense in the Transposon Arms Race
Aravin, A. A., Hannon, G. J., & Brennecke, J. (2007) · Science · doi:10.1126/science.1146484 · Cited by 1,096
Strategies for silencing human disease using RNA interference
Kim, D. H., & Rossi, J. J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2006 · Cited by 1,078
RNA interference in adult mice
McCaffrey, A. P., Meuse, L., Pham, T.-T. T., Conklin, D. S., Hannon, G. J., & Kay, M. A. (2002) · Nature · doi:10.1038/418038a · Cited by 1,059
Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes
Tam, O. H., Aravin, A. A., Stein, P., Girard, A., Murchison, E. P., Cheloufi, S., Hodges, E., Anger, M., Sachidanandam, R., Schultz, R. M., et al. (2008) · Nature · doi:10.1038/nature06904 · Cited by 1,044
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
Song, E., Zhu, P., Lee, S.-K., Chowdhury, D., Kussman, S., Dykxhoorn, D. M., Feng, Y., Palliser, D., Weiner, D. B., Shankar, P., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1101 · Cited by 1,021
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,002
Induction of an interferon response by RNAi vectors in mammalian cells
Bridge, A. J., Pebernard, S., Ducraux, A., Nicoulaz, A.-L., & Iggo, R. (2003) · Nature Genetics · doi:10.1038/ng1173 · Cited by 961
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G., & Bernards, R. (2003) · Nature · doi:10.1038/nature01811 · Cited by 952
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Kleinman, M. E., Yamada, K., Takeda, A., Chandrasekaran, V., Nozaki, M., Baffi, J. Z., Albuquerque, R. J. C., Yamasaki, S., Itaya, M., Pan, Y., et al. (2008) · Nature · doi:10.1038/nature06765 · Cited by 929
3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets
Birmingham, A., Anderson, E. M., Reynolds, A., Ilsley-Tyree, D., Leake, D., Fedorov, Y., Baskerville, S., Maksimova, E., Robinson, K., Karpilow, J., et al. (2006) · Nature Methods · doi:10.1038/nmeth854 · Cited by 920
Wajapeyee, N., Serra, R. W., Zhu, X., Mahalingam, M., & Green, M. R. (2008) · Cell · doi:10.1016/j.cell.2007.12.032 · Cited by 903
Stable suppression of tumorigenicity by virus-mediated RNA interference
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00122-8 · Cited by 886
Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy
Kim, D.-H., Behlke, M. A., Rose, S. D., Chang, M.-S., Choi, S., & Rossi, J. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1051 · Cited by 884
siRNA function in RNAi: A chemical modification analysis
CHIU, Y.-L., & RANA, T. M. (2003) · RNA · doi:10.1261/rna.5103703 · Cited by 860
Zeng, Y., Wagner, E. J., & Cullen, B. R. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00541-5 · Cited by 831
Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing
Jackson, A. L., Burchard, J., Leake, D., Reynolds, A., Schelter, J., Guo, J., Johnson, J. M., Lim, L., Karpilow, J., Nichols, K., et al. (2006) · RNA · doi:10.1261/rna.30706 · Cited by 789
Argonaute2 Cleaves the Anti-Guide Strand of siRNA during RISC Activation
Rand, T. A., Petersen, S., Du, F., & Wang, X. (2005) · Cell · doi:10.1016/j.cell.2005.10.020 · Cited by 784
Inhibition of respiratory viruses by nasally administered siRNA
Bitko, V., Musiyenko, A., Shulyayeva, O., & Barik, S. (2005) · Nature Medicine · doi:10.1038/nm1164 · Cited by 725
Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor
Holen, T. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.8.1757 · Cited by 706
In vivo imaging of siRNA delivery and silencing in tumors
Medarova, Z., Pham, W., Farrar, C., Petkova, V., & Moore, A. (2007) · Nature Medicine · doi:10.1038/nm1486 · Cited by 697
siRNA Delivery into Human T Cells and Primary Cells with Carbon‐Nanotube Transporters
Liu, Z., Winters, M., Holodniy, M., & Dai, H. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200604295 · Cited by 666
Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies
Sen, G. L., & Blau, H. M. (2005) · Nature Cell Biology · doi:10.1038/ncb1265 · Cited by 644
Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells
Czauderna, F. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg393 · Cited by 623
The Double-Stranded RNA-Dependent Protein Kinase PKR: Structure and Function
CLEMENS, M. J., & ELIA, A. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.503 · Cited by 605
A Protein Sensor for siRNA Asymmetry
Tomari, Y., Matranga, C., Haley, B., Martinez, N., & Zamore, P. D. (2004) · Science · doi:10.1126/science.1102755 · Cited by 599
Gene therapy clinical trials worldwide to 2007—an update
Edelstein, M. L., Abedi, M. R., & Wixon, J. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1100 · Cited by 584
Virus treatment questioned after gene therapy death
Lehrman, S. (1999) · Nature · doi:10.1038/43977 · Cited by 576
Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality
Elm n, J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki193 · Cited by 559
Coyne, C. B., & Bergelson, J. M. (2006) · Cell · doi:10.1016/j.cell.2005.10.035 · Cited by 547
Tiscornia, G., Singer, O., Ikawa, M., & Verma, I. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437912100 · Cited by 540
RNA Interference in Mammalian Cells by Chemically-Modified RNA
Braasch, D. A., Jensen, S., Liu, Y., Kaur, K., Arar, K., White, M. A., & Corey, D. R. (2003) · Biochemistry · doi:10.1021/bi0343774 · Cited by 531
Sfold web server for statistical folding and rational design of nucleic acids
Ding, Y., Chan, C. Y., & Lawrence, C. E. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh449 · Cited by 518
Specificity of short interfering RNA determined through gene expression signatures
Semizarov, D., Frost, L., Sarthy, A., Kroeger, P., Halbert, D. N., & Fesik, S. W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131959100 · Cited by 501
Off-target effects by siRNA can induce toxic phenotype
Fedorov, Y., Anderson, E. M., Birmingham, A., Reynolds, A., Karpilow, J., Robinson, K., Leake, D., Marshall, W. S., & Khvorova, A. (2006) · RNA · doi:10.1261/rna.28106 · Cited by 490
Interactions between double-stranded RNA regulators and the protein kinase DAI.
Manche, L., Green, S. R., Schmedt, C., & Mathews, M. B. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.11.5238 · Cited by 483
Harborth, J., Elbashir, S. M., Vandenburgh, K., Manninga, H., Scaringe, S. A., Weber, K., & Tuschl, T. (2003) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729003321629638 · Cited by 474
Nonviral delivery of synthetic siRNAs in vivo
Akhtar, S., & Benter, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33494 · Cited by 464
Aptamer mediated siRNA delivery
Chu, T. C. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl388 · Cited by 446
Synthetic shRNAs as potent RNAi triggers
Siolas, D., Lerner, C., Burchard, J., Ge, W., Linsley, P. S., Paddison, P. J., Hannon, G. J., & Cleary, M. A. (2005) · Nature Biotechnology · doi:10.1038/nbt1052 · Cited by 445
Inhibition of influenza virus production in virus-infected mice by RNA interference
Ge, Q., Filip, L., Bai, A., Nguyen, T., Eisen, H. N., & Chen, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402486101 · Cited by 444
Small RNAs with Imperfect Match to Endogenous mRNA Repress Translation
Saxena, S., Jónsson, Z. O., & Dutta, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307089200 · Cited by 436
In vitro reconstitution of the human RISC-loading complex
MacRae, I. J., Ma, E., Zhou, M., Robinson, C. V., & Doudna, J. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710869105 · Cited by 434
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
Juliano, R., Alam, M. R., Dixit, V., & Kang, H. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn342 · Cited by 429
Human Immunodeficiency Virus Type 1 Escapes from RNA Interference-Mediated Inhibition
Das, A. T., Brummelkamp, T. R., Westerhout, E. M., Vink, M., Madiredjo, M., Bernards, R., & Berkhout, B. (2004) · Journal of Virology · doi:10.1128/jvi.78.5.2601-2605.2004 · Cited by 424
Progress in antisense technology
Crooke, S. T. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104408 · Cited by 417
Human Immunodeficiency Virus Type 1 Escape from RNA Interference
Boden, D., Pusch, O., Lee, F., Tucker, L., & Ramratnam, B. (2003) · Journal of Virology · doi:10.1128/jvi.77.21.11531-11535.2003 · Cited by 412
Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo
Bertrand, J.-R., Pottier, M., Vekris, A., Opolon, P., Maksimenko, A., & Malvy, C. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02013-2 · Cited by 400
Warnecke, C., Zaborowska, Z., Kurreck, J., Erdmann, V. A., Frei, U., Wiesener, M., & Eckardt, K. (2004) · The FASEB Journal · doi:10.1096/fj.04-1640fje · Cited by 398
Self-citationDesign of a genome-wide siRNA library using an artificial neural network
Huesken, D., Lange, J., Mickanin, C., Weiler, J., Asselbergs, F., Warner, J., Meloon, B., Engel, S., Rosenberg, A., Cohen, D., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1118 · Cited by 386
Cancer Proliferation Gene Discovery Through Functional Genomics
Schlabach, M. R., Luo, J., Solimini, N. L., Hu, G., Xu, Q., Li, M. Z., Zhao, Z., Smogorzewska, A., Sowa, M. E., Ang, X. L., et al. (2008) · Science · doi:10.1126/science.1149200 · Cited by 380
A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V, Fisch, G., Dames, S., Löffler, K., Fechtner, M., Arnold, W., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302777 · Cited by 368
Wang, Z., Ma, H.-I., Li, J., Sun, L., Zhang, J., & Xiao, X. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302133 · Cited by 367
Prospects of RNA interference therapy for cancer
Pai, S. I., Lin, Y.-Y., Macaes, B., Meneshian, A., Hung, C.-F., & Wu, T.-C. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302694 · Cited by 352
Grimm, D., & Kay, M. (2003) · Current Gene Therapy · doi:10.2174/1566523034578285 · Cited by 350
RNA interference and chemically modified small interfering RNAs
Manoharan, M. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.10.007 · Cited by 346
RNA and microRNAs in fragile X mental retardation
Jin, P., Alisch, R. S., & Warren, S. T. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1048 · Cited by 346
Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells
Lorenz, C., Hadwiger, P., John, M., Vornlocher, H.-P., & Unverzagt, C. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.07.018 · Cited by 338
Local gene knockdown in the brain using viral-mediated RNA interference
Hommel, J. D., Sears, R. M., Georgescu, D., Simmons, D. L., & DiLeone, R. J. (2003) · Nature Medicine · doi:10.1038/nm964 · Cited by 334
Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1
Shen, J., Samul, R., Silva, R. L., Akiyama, H., Liu, H., Saishin, Y., Hackett, S. F., Zinnen, S., Kossen, K., Fosnaugh, K., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302641 · Cited by 307
Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155
Chung, K.-H. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl143 · Cited by 306
Gutless adenovirus: last-generation adenovirus for gene therapy
Alba, R., Bosch, A., & Chillon, M. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302612 · Cited by 303
RNA interference against viruses: strike and counterstrike
Haasnoot, J., Westerhout, E. M., & Berkhout, B. (2007) · Nature Biotechnology · doi:10.1038/nbt1369 · Cited by 295
Kretschmer-Kazemi Far, R. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg649 · Cited by 291
Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication†
Morrissey, D. V., Blanchard, K., Shaw, L., Jensen, K., Lockridge, J. A., Dickinson, B., McSwiggen, J. A., Vargeese, C., Bowman, K., Shaffer, C. S., et al. (2005) · Hepatology · doi:10.1002/hep.20702 · Cited by 290
Wu, H., Hait, W. N., & Yang, J. (2003) · PubMed · Cited by 289
Bitko, V., & Barik, S. (2001) · BMC Microbiology · doi:10.1186/1471-2180-1-34 · Cited by 287
Chemical modification: the key to clinical application of RNA interference?
Corey, D. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33483 · Cited by 285
Perspectives on Chemistry and Therapeutic Applications of Locked Nucleic Acid (LNA)
Kaur, H., Babu, B. R., & Maiti, S. (2007) · Chemical Reviews · doi:10.1021/cr050266u · Cited by 285
Lentiviral-Mediated RNA Interference
Abbas-Terki, T., Blanco-Bose, W., Déglon, N., Pralong, W., & Aebischer, P. (2002) · Human Gene Therapy · doi:10.1089/104303402320987888 · Cited by 284
Shi, Y. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(02)00005-7 · Cited by 280
Grunweller, A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg409 · Cited by 269
Small interfering RNA and gene silencing in transgenic mice and rats
Hasuwa, H., Kaseda, K., Einarsdottir, T., & Okabe, M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03680-3 · Cited by 266
The 2–5 A system: Modulation of viral and cellular processes through acceleration of RNA degradation
Player, M. R., & Torrence, P. F. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00167-8 · Cited by 264
Honore, P., Wismer, C. T., Mikusa, J., Zhu, C. Z., Zhong, C., Gauvin, D. M., Gomtsyan, A., El Kouhen, R., Lee, C.-H., Marsh, K., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.083915 · Cited by 253
DEVINCENZO, J., CEHELSKY, J., ALVAREZ, R., ELBASHIR, S., HARBORTH, J., TOUDJARSKA, I., NECHEV, L., MURUGAIAH, V, VLIET, A., & VAISHNAW, A. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2007.11.009 · Cited by 247
Schubert, S., Grünweller, A., Erdmann, V. A., & Kurreck, J. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.011 · Cited by 244
Self-citationLi, M.-J., Kim, J., Li, S., Zaia, J., Yee, J.-K., Anderson, J., Akkina, R., & Rossi, J. J. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.07.524 · Cited by 241
Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition
Brake, O. T., Hooft, K. '., Liu, Y. P., Centlivre, M., Jasmijn von Eije, K., & Berkhout, B. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300382 · Cited by 239
Gitlin, L., Stone, J. K., & Andino, R. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1027-1035.2005 · Cited by 235
Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins
Boden, D. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh278 · Cited by 229
Transcription and RNAi in heterochromatic gene silencing
Bühler, M., & Moazed, D. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1315 · Cited by 228
siRNA and isRNA: two edges of one sword
Schlee, M., Hornung, V., & Hartmann, G. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.06.001 · Cited by 216
The human RNA kinase hClp1 is active on 3′ transfer RNA exons and short interfering RNAs
Weitzer, S., & Martinez, J. (2007) · Nature · doi:10.1038/nature05777 · Cited by 211
Germline transmission of RNAi in mice
Carmell, M. A., Zhang, L., Conklin, D. S., Hannon, G. J., & Rosenquist, T. A. (2003) · Nature Structural Biology · doi:10.1038/nsb896 · Cited by 195
Improved silencing properties using small internally segmented interfering RNAs
Bramsen, J. B., Laursen, M. B., Damgaard, C. K., Lena, S. W., Ravindra Babu, B., Wengel, J., & Kjems, J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm548 · Cited by 192
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V, Durieux, B., Löffler, K., Fechtner, M., Röhl, T., Fisch, G., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302778 · Cited by 183
Evaluation of locked nucleic acid–modified small interfering RNA in vitro and in vivo
Mook, O. R., Baas, F., de Wissel, M. B., & Fluiter, K. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0195 · Cited by 182
Effect of target secondary structure on RNAi efficiency
Shao, Y., Chan, C. Y., Maliyekkel, A., Lawrence, C. E., Roninson, I. B., & Ding, Y. (2007) · RNA · doi:10.1261/rna.546207 · Cited by 168
Experimental validation of the importance of seed complement frequency to siRNA specificity
Anderson, E. M., Birmingham, A., Baskerville, S., Reynolds, A., Maksimova, E. M., Leake, D., Federov, Y., Karpilow, J. M., & Khvorova, A. (2008) · RNA · doi:10.1261/rna.704708 · Cited by 165
Locked Nucleic Acid Oligonucleotides: The Next Generation of Antisense Agents?
Gr??nweller, A., & Hartmann, R. K. (2007) · BioDrugs · doi:10.2165/00063030-200721040-00004 · Cited by 164
Local RNA Target Structure Influences siRNA Efficacy: A Systematic Global Analysis
Overhoff, M., Alken, M., Far, R. K.-K., Lemaitre, M., Lebleu, B., Sczakiel, G., & Robbins, I. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.012 · Cited by 164
Design of siRNAs producing unstructured guide-RNAs results in improved RNA interference efficiency
Patzel, V., Rutz, S., Dietrich, I., Köberle, C., Scheffold, A., & Kaufmann, S. H. E. (2005) · Nature Biotechnology · doi:10.1038/nbt1151 · Cited by 155
(2003) · Nature Cell Biology · doi:10.1038/ncb0603-490 · Cited by 153
RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA
Turner, J. J., Jones, S. W., Fabani, M. M., Ivanova, G. D., Arzumanov, A. A., & Gait, M. J. (2006) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2006.10.003 · Cited by 151
Gene Silencing by Double‐Stranded RNA (Nobel Lecture)
Fire, A. Z. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200701979 · Cited by 151
Target accessibility dictates the potency of human RISC
Brown, K. M., Chu, C., & Rana, T. M. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb931 · Cited by 149
Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway
John, M., Constien, R., Akinc, A., Goldberg, M. S., Moon, Y.-A., Spranger, M., Hadwiger, P., Soutschek, J., Vornlocher, H., Manoharan, M., et al. (2007) · Nature · doi:10.1038/nature06179 · Cited by 144
Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo
Christoph, T., Grünweller, A., Mika, J., Schafer, M. K.-H., Wade, E. J., Weihe, E., Erdmann, V. A., Frank, R., Gillen, C., & Kurreck, J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.037 · Cited by 143
Self-citationSuppression of prion protein in livestock by RNA interference
Golding, M. C., Long, C. R., Carmell, M. A., Hannon, G. J., & Westhusin, M. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600813103 · Cited by 139
A systematic analysis of the effect of target RNA structure on RNA interference
Westerhout, E. M., & Berkhout, B. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm437 · Cited by 137
von Eije, K. J., ter Brake, O., & Berkhout, B. (2007) · Journal of Virology · doi:10.1128/jvi.02035-07 · Cited by 124
Henry, S. D., van der Wegen, P., Metselaar, H. J., Tilanus, H. W., Scholte, B. J., & van der Laan, L. J. W. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.04.012 · Cited by 116
Reversible gene knockdown in mice using a tight, inducible shRNA expression system
Seibler, J., Kleinridders, A., Birgit, K.-L., Sandra, N., Brüning, J. C., & Schwenk, F. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm122 · Cited by 115
Single copy shRNA configuration for ubiquitous gene knockdown in mice
Seibler, J., Birgit, K.-L., Kern, H., Streu, S., Plum, L., Mauer, J., hn, R. K. ⁄., Brüning, J. C., & Schwenk, F. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni065 · Cited by 109
RNAi and Gene Therapy: A Mutual Attraction
Grimm, D., & Kay, M. A. (2007) · Hematology · doi:10.1182/asheducation-2007.1.473 · Cited by 102
Corey, D. R. (2006) · Nature Chemical Biology · doi:10.1038/nchembio0107-8 · Cited by 97
Insights into Effective RNAi Gained from Large-Scale siRNA Validation Screening
Krueger, U., Bergauer, T., Kaufmann, B., Wolter, I., Pilk, S., Heider-Fabian, M., Kirch, S., Artz-Oppitz, C., Isselhorst, M., & Konrad, J. (2007) · Oligonucleotides · doi:10.1089/oli.2006.0065 · Cited by 95
Locked Nucleic Acid: High-Affinity Targeting of Complementary RNA for RNomics
Kauppinen, S., Vester, B., & Wengel, J. (2006) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-27262-3_21 · Cited by 89
The Business of RNAi Therapeutics
Haussecker, D. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.007 · Cited by 87
siRNA Efficiency: Structure or Sequence—That Is the Question
Kurreck, J. (2006) · BioMed Research International · doi:10.1155/jbb/2006/83757 · Cited by 87
Self-citationInvestigation of TRPV1 loss-of-function phenotypes in transgenic shRNA expressing and knockout mice
Christoph, T., Bahrenberg, G., Vry, J. D., Englberger, W., Erdmann, V. A., Frech, M. J., Kögel, B. Y., Röhl, T., Schiene, K., Schröder, W., et al. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.12.006 · Cited by 85
Self-citationAntitumor Activity of an Oncolytic Adenovirus-Delivered Oncogene Small Interfering RNA
Zhang, Y., Nemunaitis, J. J., Samuel, S. K., Chen, P., Shen, Y., & Tong, A. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1617 · Cited by 80
Maintaining Inhibition: siRNA Double Expression Vectors Against Coxsackieviral RNAs
Schubert, S., Grunert, H., Zeichhardt, H., Werk, D., Erdmann, V. A., & Kurreck, J. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.11.074 · Cited by 78
Self-citationDevelopment of Therapeutic siRNAs for Pachyonychia Congenita
Smith, F. J. D., Hickerson, R. P., Sayers, J. M., Reeves, R. E., Contag, C. H., Leake, D., Kaspar, R. L., & McLean, W. H. I. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701040 · Cited by 75
Enzymatically prepared RNAi libraries
Buchholz, F., Kittler, R., Slabicki, M. M., & Theis, M. (2006) · Nature Methods · doi:10.1038/nmeth912 · Cited by 67
Werk, D., Schubert, S., Lindig, V., Grunert, H., Zeichhardt, H., Erdmann, V. A., & Kurreck, J. (2005) · Biological Chemistry · doi:10.1515/bc.2005.100 · Cited by 67
Self-citationsiRNA Delivery into Human T Cells and Primary Cells with Carbon‐Nanotube Transporters
Liu, Z., Winters, M. A., Holodniy, M., & Dai, H. (2007) · Angewandte Chemie · doi:10.1002/ange.200604295 · Cited by 67
Suppression of human brain tumor with interference RNA specific for tenascin-C
Zukiel, R., & Nowak, S. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.8.2886 · Cited by 65
Anderson, J. S., & Akkina, R. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302958 · Cited by 64
The interplay between virus infection and the cellular RNA interference machinery
Berkhout, B., & Haasnoot, J. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.070 · Cited by 63
Conditional gene knock‐down by CRE‐dependent short interfering RNAs
Fritsch, L., Martinez, L. A., Sekhri, R., Naguibneva, I., Gérard, M., Vandromme, M., Schaeffer, L., & Harel‐Bellan, A. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400064 · Cited by 59
Phosphorothioate‐stimulated uptake of short interfering RNA by human cells
Overhoff, M. G., & Sczakiel, G. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400535 · Cited by 58
Return to the RNAi World: Rethinking Gene Expression and Evolution (Nobel Lecture)
Mello, C. C. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200701713 · Cited by 58
Fechner, H., Pinkert, S., Wang, X., Sipo, I., Suckau, L., Kurreck, J., Dörner, A., Sollerbrant, K., Zeichhardt, H., Grunert, H. ‐., et al. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302948 · Cited by 48
Self-citationFechner, H., Suckau, L., Kurreck, J., Sipo, I., Wang, X., Pinkert, S., Loschen, S., Rekittke, J., Weger, S., Dekkers, D. H. W., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302872 · Cited by 47
Self-citationOosterkamp, H. M., Neering, H., Nijman, S. M. B., Dirac, A. M. G., Mooi, W. J., Bernards, R., & Brummelkamp, T. R. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07224.x · Cited by 46
Silencing of mammalian genes by tetracycline-inducible shRNA expression
Kappel, S., Matthess, Y., Kaufmann, M., & Strebhardt, K. (2007) · Nature Protocols · doi:10.1038/nprot.2007.458 · Cited by 41
Tissue-specific and cell type–specific RNA interference in vivo
Rao, M. K., & Wilkinson, M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.260 · Cited by 40
RNA interference in pain research
Röhl, T., & Kurreck, J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04082.x · Cited by 39
Self-citationReceptor-mediated delivery of siRNAs by tethered nucleic acid base-paired interactions
Zhang, K., Wang, Q., Xie, Y., Mor, G., Sega, E. I., Low, P. S., & Huang, Y. (2008) · RNA · doi:10.1261/rna.739308 · Cited by 37
Grünweller, A., Gillen, C., Erdmann, V. A., & Kurreck, J. (2003) · Oligonucleotides · doi:10.1089/154545703322617023 · Cited by 34
Self-citationMerl, S., & Wessely, R. (2007) · Oligonucleotides · doi:10.1089/oli.2007.0057 · Cited by 32
Tumor inhibition by genomically integrated inducible RNAi-cassettes
Kappel, S., Matthess, Y., Zimmer, B., Kaufmann, M., & Strebhardt, K. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl628 · Cited by 32
miRNAs in the Biology of Cancers and Viral Infections
Yeung, M. L., Bennasser, Y., & Jeang, K. (2006) · Current Medicinal Chemistry · doi:10.2174/092986707779313417 · Cited by 30
Schubert, S., Rothe, D., Werk, D., Grunert, H., Zeichhardt, H., Erdmann, V. A., & Kurreck, J. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.10.005 · Cited by 26
Self-citationChatterjee‐Kishore, M., & Miller, C. P. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03623-8 · Cited by 24
Zurück zur RNAi‐Welt: Gedanken zur Genexpression und Evolution (Nobel‐Vortrag)
Mello, C. C. (2007) · Angewandte Chemie · doi:10.1002/ange.200701713 · Cited by 18
Gen‐Stummschaltung durch doppelsträngige RNA (Nobel‐Vortrag)
Fire, A. Z. (2007) · Angewandte Chemie · doi:10.1002/ange.200701979 · Cited by 16
Trends in biotech literature 2006
Taroncher‐Oldenburg, G., & Marshall, A. (2007) · Nature Biotechnology · doi:10.1038/nbt0907-961 · Cited by 14
Han, Z., Gorbatyuk, M. S., Thomas, J. W., Lewin, A. S., Srivastava, A., & Stacpoole, P. W. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.02.003 · Cited by 13
Focusing on RISC assembly in mammalian cells
Hong, J., Wei, N., Chalk, A. M., Wang, J., Song, Y., Fan, Y., Qiao, R., Sonnhammer, E. L. L., Wahlestedt, C., Liang, Z., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.116 · Cited by 13
Strategies for the Delivery of Oligonucleotides in vivo
Reinsch, C., Siepi, E., Dieckmann, A., & Panzner, S. (2008) · Royal Society of Chemistry eBooks · doi:10.1039/9781847558275-00226 · Cited by 4
Immune Stimulatory Oligonucleotides
Uhlmann, E. (2008) · Royal Society of Chemistry eBooks · doi:10.1039/9781847558275-00142 · Cited by 3
RNA Based Therapies for Treatment of HIV Infection
Scherer, L. J., Weinberg, M. S., & Rossi, J. J. (2008) · Royal Society of Chemistry eBooks · doi:10.1039/9781847558275-00316 · Cited by 3
Vector-Mediated and Viral Delivery of Short Hairpin RNAs
Fechner, H., & Kurreck, J. (2008) · Royal Society of Chemistry eBooks · doi:10.1039/9781847558275-00267 · Cited by 3
Self-citationLipid-Mediated in vivo Delivery of Small Interfering RNAs
MacLachlan, I. (2008) · Royal Society of Chemistry eBooks · doi:10.1039/9781847558275-00241 · Cited by 2
Cited by
Mechanisms of dsRNA uptake in insects and potential of RNAi for pest control: A review
Huvenne, H., & Smagghe, G. (2010) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2009.10.004 · Cited by 966
Application of calcium phosphatenanoparticles in biomedicine
Epple, M., Ganesan, K., Heumann, R., Klesing, J., Kovtun, A., Neumann, S., & Sokolova, V. (2010) · J. Mater. Chem. · doi:10.1039/b910885h · Cited by 333
The how and why of lncRNA function: An innate immune perspective
Robinson, E. K., Covarrubias, S., & Carpenter, S. (2020) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.194419 · Cited by 285
Cellular Uptake and Intracellular Trafficking of Antisense and siRNA Oligonucleotides
Juliano, R. L., Ming, X., & Nakagawa, O. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200377d · Cited by 181
Huili, W., Xiaokai, Z., Meili, L., Dahlgren, R. A., Wei, C., Jaiopeng, Z., Chengyang, X., Chunlei, J., Yi, X., Xuedong, W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083485 · Cited by 15
Metadata
- Authors
- Kurreck, J.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2009-01-30
- Volume
- 48
- Issue
- 8
- Pages
- 1378-1398
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2159955926
- Cited by
- 335
- References
- 178
- FWCI
- 17.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.